US FDA issues warning letter to Glenmark for its Baddi facility Press Trust of India Oct 7, 2019 US FDA had inspected the facility between April 15 and April 20 and earlier classified the inspection as an official action…
Lupin gets warning letter from US FDA for Mandideep facility Press Trust of India Sep 19, 2019 Lupin said there are no drug master file and abbreviated new drug applications (ANDA) pending review or approval from the…
Indoco’s Goa Plant I receives Warning Letter from US FDA EP News Bureau Jul 17, 2019 The facility had received six observations in Form 483s and was classified as ‘OAI’ (Official Action Indicated’) in March 2019
